Records containing: Still Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-08Non-interventional Study on the Use of ILARIS® (Canakinumab) Among Familial Mediterranean Fever and Still's Disease Patients Across Europe and Israel
-
CLINICAL_TRIALS study record update · 2026-02-19A Two-cohort, Open-label, Single Arm, Multicenter Study to Evaluate Efficacy, Safety and Tolerability, PK and PD, of Emapalumab in Children and Adults With MAS in Still's Disease or With MAS in Systemic Lupus Erythematous
-
CLINICAL_TRIALS study record update · 2026-02-12Cohorte d'Adultes et d'Enfants Avec Maladie de Still
-
CLINICAL_TRIALS study record update · 2025-08-17Clinical Autoinflammatory Disease Cohort
-
CLINICAL_TRIALS study record update · 2025-07-22EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-07-10Development of an International Multicenter Registry of Patients With Monogenic and Polygenic Autoinflammatory Diseases Aimed at Clinical and Therapeutical Data Collection and Analysis
-
CLINICAL_TRIALS study record update · 2024-04-26Auvergne-Rhône-Alpes-Limousin Research Database for Still's Diseases in Children and Adults
-
CLINICAL_TRIALS study record update · 2022-04-26Observational Retrospective Studies on Single Nucleotide Variants (SNPs) on the Interleukin-6 Receptor (IL6R) and Their Influence on the Response to Treatment and Safety in Patients With Specific Rheumatic Diseases
-
CLINICAL_TRIALS study record update · 2022-02-15A Clinical Study on the Safety and Effectiveness of Targeting CD7 Chimeric Antigen Receptor T Cells in the Treatment of Autoimmune Diseases